We are Sorry, This Page doesn't Exist

Teva Stock Falls as Novartis Brings Another Copaxone Generic

Teva's (TEVA) shares fall as Novartis launches the second generic version of the 40 mg formulation of Copaxone Shares of Teva Pharmaceutical Industries Limited TEVA were down around 4% on Tuesday, a.....»»

Category: smallbizSource: nytFeb 14th, 2018

Is Teva Finally Back on Track?

Teva Pharmaceutical saw its shares make a small gain on Wednesday after the firm announced the exclusive launch of a generic version of Reyataz capsules in the United States......»»

Category: blogSource: 247wallstDec 27th, 2017

Teva Pharmaceutical set for major layoffs in Israel, U.S.: report

TEL AVIV (Reuters) - Teva Pharmaceutical Industries is expected to cut 20-25 percent of its 6,860 workers in Israel and a few thousand more in the United States, financial news website Calcalist reported on Thursday......»»

Category: topSource: reutersNov 23rd, 2017

Teva Submits BLA to FDA for Migraine Candidate Fremanezumab

Teva Pharma (TEVA) submits BLA seeking approval for its pipeline candidate, Fremanezumab, as a preventive treatment for migraine in the United States. Teva Pharmaceutical Industries.....»»

Category: worldSource: nytOct 19th, 2017

Mesoblast"s Delayed Launches, Teva Split Turn Credit Suisse Bearish

Mesoblast limited (ADR) (NASDAQ: MESO), a developer of adult stem cell-based products, has struggled to meet key clinical timelines and lost a key partnership with Teva Pharmaceutical Industries Ltd (ADR) ADR Latest Ratings for MESO .....»»

Category: blogSource: benzingaMar 22nd, 2018

Teva shares drop 3% after rival generic product approved and launched

Teva Pharmaceutical Industries Ltd. shares dropped 3% in premarket trade Tuesday after Novartis AG's Sandoz announced that the 40 mg dose of Glatopa, its generic for Teva.....»»

Category: topSource: marketwatchFeb 13th, 2018

Mylan sees opportunity in rival Teva’s weakness

Challenging conditions in the U.S. generic drug market have hit drugmaker Teva Pharmaceutical Industries Ltd. particularly hard......»»

Category: topSource: marketwatchJan 9th, 2018

Teva to launch generic version of Gilead"s Viread in the U.S.

Shares of Teva Pharmaceutical Industries Ltd. .....»»

Category: topSource: marketwatchDec 15th, 2017

Teva, the world"s largest generic drugmaker, is cutting 14,000 workers

Teva Pharmaceutical Industries Ltd., the worl.....»»

Category: topSource: latimesDec 14th, 2017

Largest generic drugmaker Teva to cut 14000 workers worldwide - Los Angeles Times

Los Angeles TimesLargest generic drugmaker Teva to cut 14000 workers worldwideLos Angeles TimesTeva Pharmaceutical Industries Ltd., the world's largest generic drug m.....»»

Category: topSource: googlenewsDec 14th, 2017

Largest generic drugmaker Teva to cut 14,000 workers worldwide

Teva Pharmaceutical Industries Ltd., the wor.....»»

Category: topSource: latimesDec 14th, 2017

Israeli drugmaker Teva to cut quarter of global work force

Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, says it is laying off 14,000 workers as part of a global restructuring......»»

Category: topSource: foxnewsDec 14th, 2017

Teva"s stock gains after exclusive launch of generic Viagra

Shares of Teva Pharmaceutical Industries Ltd. rose 0.4% in morning trade Monday, after the drug maker announced the exclusive launch of its generic Viagra tablets in the U.S. The company said it will offer support services for its sildenafil tablets.....»»

Category: topSource: marketwatchDec 11th, 2017

Teva Pharmaceutical Is Reportedly Planning Thousands of Layoffs in the U.S.

The world's largest generic drugmaker will terminate "tens of percents" of its 10,000 U.S. workers. Teva Pharmaceutical Industries teva is expected to cut 20-25% of its workforce in.....»»

Category: europeSource: fortuneNov 23rd, 2017

Teva"s stock drops after J.P. Morgan downgrades to rare bearish rating

Shares of Teva Pharmaceutical Industries Ltd. shed 2.2% in premarket trade Monday, after the generic drug maker was downgraded at J.P. Morgan to a rare bearish rating, citing concerns ove.....»»

Category: topSource: marketwatchNov 13th, 2017

Teva"s stock, bonds fall after credit rating slashed to junk at Fitch

Shares of Teva Pharmaceutical Industries Ltd. sank 3.6% in premarket trade Tuesday, after the Israel-based generic drug maker's credit rating was cut by two notches into "junk" territory by Fitch Ratings. Teva's most active bonds, the 3.....»»

Category: topSource: marketwatchNov 7th, 2017

Generic drugmakers, distributor shares slide after Teva reports worse pricing environment

Generic drugmakers and drug distributors' shares sunk in Thursday trade after Teva Pharmaceutical Industries Ltd. reported worse price erosion for generic drugs in the latest quarter and lowered its 2017 guidance. Teva.....»»

Category: topSource: marketwatchNov 2nd, 2017

Shares of large generic drugmakers fall

Shares of several large generic drugmakers fell in Wednesday midday trade. Mylan NV shares dropped 2.7%, Teva Pharmaceutical Industries Ltd. shares dropped 2.1% , Taro Pharmaceutical Industries .....»»

Category: topSource: marketwatchOct 18th, 2017

Thursday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Netflix, Inc. (NFLX) and JPMorgan Chase & Co. (JPM)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Teva (TEVA) options surge on Mylan N.V.’s generic .....»»

Category: topSource: investorplaceOct 5th, 2017

Mylan"s Generic Copaxone Arrives, Teva Sales To Take A Hit

The FDA dealt yet another blow to struggling Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) investors by approving rival Mylan N.V. (NASDAQ: MYL)’s generic version of Teva’s Copaxone multiple sclerosis drug. Latest Ratings .....»»

Category: blogSource: benzingaOct 4th, 2017